NNVC logo

NanoViricides (NNVC) Cash From Financing

Annual CFF

$3.12 M
+$3.21 M+3391.14%

June 30, 2024

Summary

Performance

1-Year Change

+3391.14%

3-Year Change

-79.56%

5-Year Change

+32.77%

15-Year Change

+412%

NNVC Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

43.07%
NNVC annual cash flow from financing activities is higher than 43.07% of companies in Healthcare sector

High & Low

All-time High

$34.34 M
NNVC annual cash flow from financing activities is currently -90.91% below its historical high of $34.34 million

3-Year Low

-$234.70 K

Earnings dates

Last Annual Earnings Report Date

Jun 30, 2024
NNVC previous annual earnings announcement was published on Jun 30, 2024

Next Annual Earnings Report Date

N/A
NNVC next annual earnings announcement has not yet been scheduled

OtherNNVCcash flowmetrics:

Annual CFI

-$156.60 K
NNVC annual cash flow from investing activities is -$156.60 thousand

Annual CFO

-$6.32 M
NNVC annual cash flow from operations is -$6.32 million

Annual FCF

-$6.47 M
NNVC annual free cash flow is -$6.47 million

Annual CAPEX

-
NNVC annual capital expenditures value is unknown

Quarterly CFF

$1.71 M
-$1.41 M-45.19%

September 1, 2024

Summary

Performance

3-Month Change

-45.19%

1-Year Change

+100%

3-Year Change

+100%

5-Year Change

+100%

NNVC Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

68.56%
NNVC quarterly cash flow from financing activities is higher than 68.56% of companies in Healthcare sector

High & Low

All-time High

$19.44 M
NNVC quarterly cash flow from financing activities is currently -91.20% below its historical high of $19.44 million

3-Year Low

-$71.00 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
NNVC previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
NNVC next earnings announcement is scheduled for Feb 14, 2025

OtherNNVCcash flowmetrics:

Quarterly CFI

-$46.80 K
NNVC quarterly cash flow from investing activities is -$46.80 thousand

Quarterly CFO

-$2.59 M
NNVC quarterly cash flow from operations is -$2.59 million

Quarterly FCF

-$2.64 M
NNVC quarterly free cash flow is -$2.64 million

Quarterly CAPEX

-
NNVC quarterly capital expenditures value is unknown

TTM CFF

$4.83 M
+$1.71 M+54.81%

September 1, 2024

Summary

Performance

3-Month Change

+54.81%

1-Year Change

+100%

3-Year Change

+5195.04%

5-Year Change

+5195.04%

NNVC TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

42.21%
NNVC TTM cash flow from financing activities is higher than 42.21% of companies in Healthcare sector

High & Low

All-time High

$34.34 M
NNVC TTM cash flow from financing activities is currently -85.93% below its historical high of $34.34 million

3-Year Low

-$272.50 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
NNVC previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
NNVC next earnings announcement is scheduled for Feb 14, 2025

OtherNNVCcash flowmetrics:

TTM CFI

-$195.10 K
NNVC TTM cash flow from investing activities is -$195.10 thousand

TTM CFO

-$7.74 M
NNVC TTM cash flow from operations is -$7.74 million

TTM FCF

-$7.93 M
NNVC TTM free cash flow is -$7.93 million

TTM CAPEX

-
NNVC TTM capital expenditures value is unknown

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

NNVC Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+3391.1%+100.0%+100.0%
3 y3 years-79.6%+100.0%+5195.0%
5 y5 years+32.8%+100.0%+5195.0%

NNVC Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-79.6%+1429.4%-45.2%+2508.6%-17.4%+1872.5%
5 y5-year-82.5%+1429.4%-83.5%+259.1%-83.0%+1872.5%
alltimeall time-90.9%+412.0%-91.2%+259.1%-85.9%+583.0%

NanoViricides Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$1.71 M(-45.2%)
$4.83 M(+54.8%)
Jun 2024
$3.12 M(-3391.1%)
$3.12 M(>+9900.0%)
$3.12 M(>+9900.0%)
Mar 2024
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2023
-
$0.00(0.0%)
$0.00(-100.0%)
Sep 2023
-
$0.00(0.0%)
-$23.80 K(-74.9%)
Jun 2023
-$94.80 K(-59.6%)
$0.00(0.0%)
-$94.80 K(-25.6%)
Mar 2023
-
$0.00(-100.0%)
-$127.50 K(-35.2%)
Dec 2022
-
-$23.80 K(-66.5%)
-$196.80 K(-16.0%)
Sep 2022
-
-$71.00 K(+117.1%)
-$234.40 K(-0.1%)
Jun 2022
-$234.70 K(-101.5%)
-$32.70 K(-52.8%)
-$234.70 K(-13.9%)
Mar 2022
-
-$69.30 K(+12.9%)
-$272.50 K(-104.7%)
Dec 2021
-
-$61.40 K(-13.9%)
$5.85 M(+21.0%)
Sep 2021
-
-$71.30 K(+1.1%)
$4.84 M(-68.3%)
Jun 2021
$15.26 M(-14.4%)
-$70.50 K(-101.2%)
$15.26 M(-38.1%)
Mar 2021
-
$6.05 M(-663.1%)
$24.65 M(-6.6%)
Dec 2020
-
-$1.07 M(-110.4%)
$26.39 M(-7.2%)
Sep 2020
-
$10.35 M(+11.1%)
$28.42 M(+59.4%)
Jun 2020
$17.83 M(+658.6%)
$9.32 M(+19.5%)
$17.83 M(+109.4%)
Mar 2020
-
$7.79 M(+712.9%)
$8.51 M(+177.5%)
Dec 2019
-
$958.90 K(-496.1%)
$3.07 M(+45.5%)
Sep 2019
-
-$242.10 K(<-9900.0%)
$2.11 M(-10.3%)
Jun 2019
$2.35 M(>+9900.0%)
$0.00(-100.0%)
$2.35 M(0.0%)
Mar 2019
-
$2.35 M(>+9900.0%)
$2.35 M(>+9900.0%)
Dec 2018
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2018
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2018
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Mar 2018
-
$0.00(0.0%)
$0.00(-100.0%)
Sep 2017
-
$0.00(0.0%)
-$1.00 M(0.0%)
Jun 2017
-$1.00 M(<-9900.0%)
$0.00(-100.0%)
-$1.00 M(0.0%)
Mar 2017
-
-$1.00 M(<-9900.0%)
-$1.00 M(<-9900.0%)
Jun 2016
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Mar 2016
-
$0.00(0.0%)
$0.00(-100.0%)
Jun 2015
$6.74 M
$0.00(0.0%)
$6.74 M(-42.6%)
Mar 2015
-
$0.00(-100.0%)
$11.74 M(-62.3%)
Dec 2014
-
$61.00 K(-99.1%)
$31.18 M(+0.1%)
DateAnnualQuarterlyTTM
Sep 2014
-
$6.68 M(+33.6%)
$31.14 M(-9.3%)
Jun 2014
$34.34 M(+427.4%)
$5.00 M(-74.3%)
$34.34 M(+17.4%)
Mar 2014
-
$19.44 M(>+9900.0%)
$29.24 M(+107.5%)
Dec 2013
-
$25.00 K(-99.7%)
$14.09 M(-14.0%)
Sep 2013
-
$9.88 M(<-9900.0%)
$16.39 M(+151.7%)
Jun 2013
$6.51 M(-30.2%)
-$97.50 K(-102.3%)
$6.51 M(-26.0%)
Mar 2013
-
$4.29 M(+84.5%)
$8.80 M(+28.9%)
Dec 2012
-
$2.32 M(>+9900.0%)
$6.83 M(-2.0%)
Sep 2012
-
$0.00(-100.0%)
$6.97 M(-25.3%)
Jun 2012
$9.33 M(+33.8%)
$2.19 M(-5.5%)
$9.33 M(-1.5%)
Mar 2012
-
$2.32 M(-6.0%)
$9.47 M(+31.9%)
Dec 2011
-
$2.46 M(+4.4%)
$7.17 M(+2.0%)
Sep 2011
-
$2.36 M(+1.5%)
$7.04 M(+0.9%)
Jun 2011
$6.97 M(-13.5%)
$2.33 M(+9200.0%)
$6.97 M(-25.8%)
Mar 2011
-
$25.00 K(-98.9%)
$9.39 M(+0.5%)
Dec 2010
-
$2.33 M(+1.3%)
$9.34 M(+30.3%)
Sep 2010
-
$2.29 M(-51.6%)
$7.17 M(-11.1%)
Jun 2010
$8.06 M(+90.6%)
$4.75 M(<-9900.0%)
$8.06 M(+93.5%)
Mar 2010
-
-$25.20 K(-116.6%)
$4.16 M(-4.0%)
Dec 2009
-
$151.60 K(-95.2%)
$4.34 M(+3.6%)
Sep 2009
-
$3.19 M(+274.8%)
$4.19 M(-1.0%)
Jun 2009
$4.23 M(+69.1%)
$850.30 K(+466.9%)
$4.23 M(+25.2%)
Mar 2009
-
$150.00 K(>+9900.0%)
$3.38 M(+4.6%)
Dec 2008
-
$0.00(-100.0%)
$3.23 M(-3.7%)
Sep 2008
-
$3.23 M(>+9900.0%)
$3.35 M(+34.1%)
Jun 2008
$2.50 M(+171.7%)
$0.00(0.0%)
$2.50 M(-25.8%)
Mar 2008
-
$0.00(-100.0%)
$3.37 M(0.0%)
Dec 2007
-
$125.00 K(-94.7%)
$3.37 M(+3.9%)
Sep 2007
-
$2.38 M(+173.0%)
$3.25 M(+252.7%)
Jun 2007
$920.00 K(-78.8%)
$870.00 K(>+9900.0%)
$920.00 K(+1740.0%)
Mar 2007
-
$0.00(0.0%)
$50.00 K(0.0%)
Dec 2006
-
$0.00(-100.0%)
$50.00 K(0.0%)
Sep 2006
-
$50.00 K
$50.00 K
Jun 2006
$4.33 M(>+9900.0%)
-
-
Jun 2005
$0.00
-
-

FAQ

  • What is NanoViricides annual cash flow from financing activities?
  • What is the all time high annual CFF for NanoViricides?
  • What is NanoViricides annual CFF year-on-year change?
  • What is NanoViricides quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for NanoViricides?
  • What is NanoViricides quarterly CFF year-on-year change?
  • What is NanoViricides TTM cash flow from financing activities?
  • What is the all time high TTM CFF for NanoViricides?
  • What is NanoViricides TTM CFF year-on-year change?

What is NanoViricides annual cash flow from financing activities?

The current annual CFF of NNVC is $3.12 M

What is the all time high annual CFF for NanoViricides?

NanoViricides all-time high annual cash flow from financing activities is $34.34 M

What is NanoViricides annual CFF year-on-year change?

Over the past year, NNVC annual cash flow from financing activities has changed by +$3.21 M (+3391.14%)

What is NanoViricides quarterly cash flow from financing activities?

The current quarterly CFF of NNVC is $1.71 M

What is the all time high quarterly CFF for NanoViricides?

NanoViricides all-time high quarterly cash flow from financing activities is $19.44 M

What is NanoViricides quarterly CFF year-on-year change?

Over the past year, NNVC quarterly cash flow from financing activities has changed by +$1.71 M (+100.00%)

What is NanoViricides TTM cash flow from financing activities?

The current TTM CFF of NNVC is $4.83 M

What is the all time high TTM CFF for NanoViricides?

NanoViricides all-time high TTM cash flow from financing activities is $34.34 M

What is NanoViricides TTM CFF year-on-year change?

Over the past year, NNVC TTM cash flow from financing activities has changed by +$4.83 M (+100.00%)